Researchers from the Harvard Medical School have developed an AI that has the ability to anticipate whether a tuberculosis ( TB ) strain will have a resistance to 10 first and second - line treatments . The neural network that was developed can identify in a tenth of a second whether the bacterium that causes TB is currently resistant with 94 % and 90 % accuracy , respectively , for first and second line drugs . Newer exams that scan sample DNA for resistance genes have their limitations, too, chiefly an inability to spot resistance for more than a handful of drugs or to detect the presence of rare resistance-promoting genetic variants. Current figures suggest that one - tenth of new TB cases are resistant to multiple treatments .
Researchers from the Harvard Medical School have developed an AI that has the ability to anticipate whether a tuberculosis ( TB ) strain will have a resistance to 10 first and second - line treatments . The neural network that was developed can identify in a tenth of a second whether the bacterium that causes TB is currently resistant with 94 % and 90 % accuracy , respectively , for first and second line drugs . Current figures suggest that one - tenth of new TB cases are resistant to multiple treatments .